We are live on ! Find out more
CARM

Carisma Therapeutics
CARM

Delisted

CARM was delisted on the 10th of October, 2025.

Back to rankings

41 hedge funds and large institutions have $40M invested in Carisma Therapeutics in 2015 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 15 increasing their positions, 7 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

114% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 7

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

20% less funds holding

Funds holding: 51 → 41 (-10)

42% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 24

66% less capital invested

Capital invested by funds: $119M → $40M (-$79.1M)

Holders
41
Holders Change
-10
Holders Change %
-19.61%
% of All Funds
1.1%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
14
Increased
15
Reduced
7
Closed
24
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$7.85M
2
RG
Redmile Group
California
+$7.21M
3
Franklin Resources
Franklin Resources
California
+$5.57M
4
O
OrbiMed
New York
+$5.16M
5
BA
BlackRock Advisors
Delaware
+$612K

Top Sellers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
-$8.62M
2
RA
Royce & Associates
New York
-$3.47M
3
JP Morgan Chase
JP Morgan Chase
New York
-$2.66M
4
AC
Ascend Capital
California
-$1.87M
5
TCM
Tekla Capital Management
Massachusetts
-$1.75M
Name Holding Trade Value Shares
Change 		Change in
Stake
SFM
51
Sphera Funds Management
Israel
– -$777K -4,356 Closed
State Street
52
State Street
Massachusetts
– -$612K -3,422 Closed
TG
53
TCW Group
California
– -$355K -1,988 Closed
PC
54
Polar Capital
United Kingdom
– -$250K -1,402 Closed
California State Teachers Retirement System (CalSTRS)
55
California State Teachers Retirement System (CalSTRS)
California
– -$84K -469 Closed
TA
56
Teachers Advisors
New York
– -$55K -307 Closed
NFA
57
Nationwide Fund Advisors
Ohio
– -$32K -179 Closed
FMA
58
FNY Managed Accounts
New York
– -$29.4K -165 Closed
TRCT
59
Tower Research Capital (TRC)
New York
– -$25K -141 Closed
CSS
60
Cubist Systematic Strategies
Connecticut
– -$23K -127 Closed
AllianceBernstein
61
AllianceBernstein
Tennessee
– -$3K -15 Closed
Barclays
62
Barclays
United Kingdom
– -$2K -7 Closed
BNP Paribas Financial Markets
63
BNP Paribas Financial Markets
France
– -$1.03K -6 Closed
RFA
64
Reilly Financial Advisors
California
– +$706 +5 New
Bank of America
65
Bank of America
North Carolina
– +$988 +7 +700%
1 2
3

CARM Hedge Fund Activity: Q2 2015 in Review

41 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Carisma Therapeutics (CARM) for Q2 2015, worth a combined $40M — down 66% from $119M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of CARM and 14 opened new positions — a net loss of 10 holders — while 7 trimmed existing stakes and 15 added.

The largest buyer was Fidelity Investments, adding an estimated $7.85M. The largest seller was Broadfin Capital, exiting entirely with an estimated $8.62M sold.

  • 41 institutional investors held Carisma Therapeutics (CARM) as of Q2 2015, down from 51 in Q1 2015.
  • Funds reported $40M of Carisma Therapeutics stock for Q2 2015, down 66% quarter-over-quarter.
  • 14 funds opened new Carisma Therapeutics positions in Q2 2015 and 24 closed out, a net change of -10 holders.
  • The largest Carisma Therapeutics buyer in Q2 2015 was Fidelity Investments, an estimated $7.85M added.
  • The largest Carisma Therapeutics seller in Q2 2015 was Broadfin Capital, an estimated $8.62M sold.

Based on aggregated 13F filings for Q2 2015.